ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S — Credit Rating and Financial Key Figures

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S (CVR number: 32323502) is a company from GENTOFTE. The company recorded a gross profit of -44610.5 kEUR in 2023. The operating profit was -44.6 mEUR, while net earnings were -44.5 mEUR. The profitability of the company measured by Return on Assets (ROA) was -199.6 %, which can be considered poor and Return on Equity (ROE) was -1321.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -100 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.